Induced by lipids and IFN-γ, SAMHD1 promotes lipid droplet accumulation, worsening liver steatosis and injury in diet-induced MASLD models through activation of the SREBP1 and SREBP2 pathways. Here, SAMHD1 is linked to metabolic dysfunction-associated steatotic liver disease.